NCT05277428View on ClinicalTrials.gov

Clinical Study to Evaluate the IBS Symptoms Improving Effect and Safety of GTB1

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

January 29, 2022

Conditions
Irritable Bowel Syndrome With Diarrhea
Interventions
DIETARY_SUPPLEMENT

GTB1

2 capsule/day

DIETARY_SUPPLEMENT

Placebo

2 capsule/day

Trial Locations (1)

17074

Amorepacific, Yongin-si

All Listed Sponsors
lead

Amorepacific Corporation

INDUSTRY

NCT05277428 - Clinical Study to Evaluate the IBS Symptoms Improving Effect and Safety of GTB1 | Biotech Hunter | Biotech Hunter